Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence.

Authors: Davelaar, Akueni L  Straub, DaniĆ«lle  Buttar, Navtej S  Fockens, Paul  Krishnadath, Kausilia K 
Citation: Davelaar AL, etal., Scand J Gastroenterol. 2015 Mar;50(3):321-32. doi: 10.3109/00365521.2014.940379. Epub 2015 Jan 6.
Pubmed: (View Article at PubMed) PMID:25562781
DOI: Full-text: DOI:10.3109/00365521.2014.940379

OBJECTIVE: Molecular processes underlying Barrett's malignant development are poorly understood. Matrix metalloproteases (MMPs) are enzymes involved in inflammation, tissue remodeling, and malignant development. Therefore, active MMPs may have a role in early metaplasia development and Barrett's esophagus' malignant progression. We desired to gain more insight into the role of MMPs during the Barrett's esophagus pathogenesis sequence.
MATERIAL AND METHODS: In a surgical Barrett's mouse model, and in nonmalignant Barrett's and malignant esophageal cell lines, the activity of MMPs was investigated using a MMP activatable probe. MMP activity was further validated in Barrett's esophagus and esophageal adenocarcinoma patient biopsies and was further differentiated by investigating MMP9 and MMP13 expressions.
RESULTS: The mouse model showed probe activation in stromal cells early on in the esophagitis and metaplasia stages. MMP probe activation was higher in the Barrett's and cancer cell lines and biopsies as compared to normal cells and tissues. Co-immunostainings confirmed that, at the tissue level, the probe activation was mostly confined to CD45-positive stromal cells. MMP13 expression was highest in Barrett's metaplasia, whereas MMP9 was highest in the esophageal adenocarcinomas.
CONCLUSION: During the Barrett's pathogenesis process, MMP activity is increased early on in the inflamed esophagus and remains high in metaplasia and esophageal adenocarcinoma. However, there is a switch of MMP13 to MMP9 expression once neoplasia develops. In the future, detecting specific MMP subtypes could be used for distinguishing nonmalignant from neoplastic Barrett's esophagus.


Disease Annotations
Objects Annotated

Additional Information

RGD Object Information
RGD ID: 13204790
Created: 2017-07-19
Species: All species
Last Modified: 2017-07-19
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.